应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
IND Xtrackers Nifty 500 India ETF
交易中 03-23 14:11:14 EDT
21.67
+0.48
+2.27%
最高
21.70
最低
21.48
成交量
1,595
今开
21.48
昨收
21.19
日振幅
1.04%
总市值
433.40万
流通市值
433.40万
总股本
20.00万
成交额
3.45万
换手率
0.80%
流通股本
20.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
印度卢比创历史新低 债券收益率升至一年高位
环球市场播报 · 03-23 11:54
印度卢比创历史新低 债券收益率升至一年高位
中东风险外溢冲击汇市 印度卢比首破93创历史新低
智通财经 · 03-20
中东风险外溢冲击汇市 印度卢比首破93创历史新低
智能戒指Oura Ring 4登陆印度市场 兼容安卓和iOS系统
CNMO科技 · 03-18
智能戒指Oura Ring 4登陆印度市场 兼容安卓和iOS系统
国际首次,中国专家用新技术再造胰岛组织,有望治愈1型糖尿病
新京报 · 03-17
国际首次,中国专家用新技术再造胰岛组织,有望治愈1型糖尿病
机构称伊朗冲突可能导致印度股市进一步下跌10%
环球市场播报 · 03-17
机构称伊朗冲突可能导致印度股市进一步下跌10%
港股异动 | 长风药业(02652)涨超17% 肺动脉高压新药IND获受理 填补国内治疗PH-ILD领域空白
智通财经 · 03-16
港股异动 | 长风药业(02652)涨超17% 肺动脉高压新药IND获受理 填补国内治疗PH-ILD领域空白
长风药业(02652)自主研发的吸入粉雾剂候选药物ICF001的IND申请获NMPA受理
智通财经 · 03-13
长风药业(02652)自主研发的吸入粉雾剂候选药物ICF001的IND申请获NMPA受理
刘纪鹏:印度股市近年为什么这么牛?与其严格的退市制度密切相关
新浪证券 · 03-13
刘纪鹏:印度股市近年为什么这么牛?与其严格的退市制度密切相关
全球改良机制!长风药业(02652)肺动脉高压新药IND获受理 精准递送平台创新转化再获里程碑
智通财经 · 03-13
全球改良机制!长风药业(02652)肺动脉高压新药IND获受理 精准递送平台创新转化再获里程碑
康宁杰瑞制药-B(09966):JSKN021的IND申请获CDE正式受理
智通财经网 · 03-13
康宁杰瑞制药-B(09966):JSKN021的IND申请获CDE正式受理
海思科(002653.SZ)获得创新药HSK44459乳膏两项适应症IND申请受理
智通财经 · 03-12
海思科(002653.SZ)获得创新药HSK44459乳膏两项适应症IND申请受理
国际油价突破100美元 印度股市跌至11个月低点
环球市场播报 · 03-12
国际油价突破100美元 印度股市跌至11个月低点
英硅智能与Liquid AI达成合作;氢溴酸他泽司他片被召回
21世纪经济报道 · 03-10
英硅智能与Liquid AI达成合作;氢溴酸他泽司他片被召回
印度卢比下跌0.5%,至1美元兑92.23卢比,因原油价格飙升
每日经济新闻 · 03-09
印度卢比下跌0.5%,至1美元兑92.23卢比,因原油价格飙升
港股异动 | 乐普生物-B(02157)午后涨超6% MRG006A 联合疗法IND获批 有望推动肝癌精准治疗
智通财经网 · 03-06
港股异动 | 乐普生物-B(02157)午后涨超6% MRG006A 联合疗法IND获批 有望推动肝癌精准治疗
港股异动 | 宜明昂科-B(01541)拉升逾16% 阿沐瑞芙普α皮下制剂IMM0306S治疗系统性红斑狼疮IND获批
智通财经 · 03-06
港股异动 | 宜明昂科-B(01541)拉升逾16% 阿沐瑞芙普α皮下制剂IMM0306S治疗系统性红斑狼疮IND获批
能源命门被卡!印度市场成中东地缘博弈下首个“牺牲品” 大摩下调评级至“持有”
智通财经 · 03-06
能源命门被卡!印度市场成中东地缘博弈下首个“牺牲品” 大摩下调评级至“持有”
港股异动 | 复宏汉霖(02696)涨超5% 自研KAT6A/B小分子抑制剂HLX97获国家药监局IND许可
智通财经 · 03-06
港股异动 | 复宏汉霖(02696)涨超5% 自研KAT6A/B小分子抑制剂HLX97获国家药监局IND许可
油价飙升推动印度卢比跌至历史新低
格隆汇 · 03-04
油价飙升推动印度卢比跌至历史新低
中东冲突导致印度股市回吐美欧贸易协议带来的全部涨幅
环球市场播报 · 03-02
中东冲突导致印度股市回吐美欧贸易协议带来的全部涨幅
加载更多
公司概况
公司名称:
Xtrackers Nifty 500 India ETF
所属市场:
NASDAQ
上市日期:
--
主营业务:
荷兰国际集团是在1991年由荷兰国民人寿保险公司和荷兰邮政银行集团合并组成的综合性财政金融集团。据美国财富(FORTUNES)杂志统计,以资产净值计算,荷兰国际集团位居全球500家大企业的第64位。在提供综合性金融财经业务方面(银行与保险业务),居世界第三位。目前,该集团在世界上65个国家和地区设有分支机构,雇员超过10万人。2000年,该集团取得税后净利润49亿欧元,同比增长24%。截至2000年底,集团资产总额达5030亿欧元。 管理结构: 在董事会下面设有四个管理运作核心,荷兰总部;国际金融财经业务部;企业和资本市场部;资产管理部。 集团总部:负责荷兰本国市场上的全部保险和银行业务。 国际金融财经业务部:所有荷兰本土以外的国际保险业、零售银行业和商业银行业的运作皆由该中心管理。其保险业务划分三大地区:欧洲和拉丁美洲、北美洲、亚澳地区。银行业务则由中心统一管理。 企业及资本市场部:所有国际货币和资本市场管理部门都由该部门管理。包括国际银行网络以及金融产品、贸易、销售、投资银行、企业银行、风险管理及调研的各项业务。 资产管理部:该部门承担企业投资者的资产和帐目管理、提供个人国际银行服务以及集团公司的保险业务的资产管理。房地产业务和信托业务也属于这个部门管理。该部门同时管理荷兰国际集团各个公司的投资基金。
发行价格:
--
{"stockData":{"symbol":"IND","market":"US","secType":"STK","nameCN":"Xtrackers Nifty 500 India ETF","latestPrice":21.67,"timestamp":1774288951382,"preClose":21.19,"halted":0,"volume":1595,"delay":0,"changeRate":0.022652194431335555,"floatShares":200001,"shares":200001,"eps":0,"marketStatus":"交易中","change":0.48,"latestTime":"03-23 14:11:14 EDT","open":21.48,"high":21.7,"low":21.48,"amount":34497.66166,"amplitude":0.010382,"askPrice":21.62,"askSize":100,"bidPrice":21.46,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1774296000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":21.19,"sharesOutstanding":200001,"nav":21.333,"aum":4266617.95,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":21.148,"preClose":21.19,"latestTime":"16:21 EDT","volume":6,"amount":129.66,"timestamp":1774038072433,"change":-0.042,"changeRate":-0.001982,"amplitude":0},"volumeRatio":0.50355},"requestUrl":"/m/hq/s/IND","defaultTab":"news","newsList":[{"id":"2621293197","title":"印度卢比创历史新低 债券收益率升至一年高位","url":"https://stock-news.laohu8.com/highlight/detail?id=2621293197","media":"环球市场播报","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621293197?lang=zh_cn&edition=full","pubTime":"2026-03-23 11:54","pubTimestamp":1774238062,"startTime":"0","endTime":"0","summary":"受美国与伊朗紧张局势升级、市场风险偏好恶化影响,印度卢比与债券价格走低。美元兑卢比上涨 0.2%,至93.8775的历史新高印度10 年期国债收益率上行 6 个基点至 6.8%,为 2025 年 1 月 15 日以来最高水平。\n\n\n海量资讯、精准解读,尽在新浪财经APP\n\n责任编辑:王永生","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-23/doc-inhrxvtx8074632.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["INDA","NFTY","EPI","INDL","SMIN","BK4588","INDY","BK4523","PIN","IND","FLIN","SCIN","BK4585"],"gpt_icon":0},{"id":"2620794200","title":"中东风险外溢冲击汇市 印度卢比首破93创历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2620794200","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620794200?lang=zh_cn&edition=full","pubTime":"2026-03-20 14:53","pubTimestamp":1773989584,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,随着中东冲突持续升级的风险引发市场对印度经常账户赤字扩大的担忧,印度卢比兑美元汇率跌破93关口,刷新历史低位。事实上在此次冲突爆发前,受美国高利率引发创纪录股票资金外流影响,印度央行已连续数月入市干预以稳定卢比汇率。外资同时也在抛售印度本地债券,3月符合指数纳入标准的债券资金流出规模达14亿美元,或将创下单月流出历史新高。该机构预计,截至6月底,卢比将贬值至1美元兑96卢比。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1416471.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4523","SMIN","EPI","IND","PIN","FLIN","SCIN","IUmain","INDL","INDY","NFTY","INDA","BK4588","BK4585"],"gpt_icon":0},{"id":"2620281671","title":"智能戒指Oura Ring 4登陆印度市场 兼容安卓和iOS系统","url":"https://stock-news.laohu8.com/highlight/detail?id=2620281671","media":"CNMO科技","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620281671?lang=zh_cn&edition=full","pubTime":"2026-03-18 12:56","pubTimestamp":1773809760,"startTime":"0","endTime":"0","summary":"近日,智能戒指品牌Oura宣布其Oura Ring 4正式在印度市场推出。Oura Ring 4具备强大的健康监测能力,可追踪超过50项健康指标,涵盖睡眠模式、心率、心率变异性、压力水平、血氧饱和度以及日间活动情况。与前代产品相比,Oura Ring 4在硬件方面实现了多项升级。Oura Ring 4提供六种配色和多种尺寸,确保用户能找到合适的款式。Oura Ring 4提供多种配色选择,银色和黑色版本售价为28900卢比,而更高端的隐秘黑、磨砂银、金色和玫瑰金版本定价为39900卢比。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://tech.ifeng.com/c/8ran68bQu1s","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fenghuang_stock","symbols":["BK4588","NFTY","EPI","IND","FLIN","INDA","BK4523","BK4585","PIN","INDY","SCIN","SMIN","INDL"],"gpt_icon":0},{"id":"2620421374","title":"国际首次,中国专家用新技术再造胰岛组织,有望治愈1型糖尿病","url":"https://stock-news.laohu8.com/highlight/detail?id=2620421374","media":"新京报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620421374?lang=zh_cn&edition=full","pubTime":"2026-03-17 19:33","pubTimestamp":1773747180,"startTime":"0","endTime":"0","summary":"“零件”再造,开辟全新技术路径糖尿病是严重威胁我国居民健康的慢性病,其中1型糖尿病多发病于儿童及青少年。3个临床病例涵盖了世界首例自体与中国首例异体再生胰岛移植治疗1型糖尿病,以及世界首例再生胰岛移植治疗青少年1型糖尿病的情况,其中最长一例已实现临床治愈超过26个月。研究提示,该疗法目前仍需联合使用长期免疫抑制治疗,用于克服1型糖尿病自身免疫复发等问题。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2026/03/17/5698057330889925556.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2026/03/17/5698057330889925556.jpg?x-oss-process=image/resize,m_lfit,w_365/quality,q_80"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1773747065129858.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1773747065129858.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["IND"],"gpt_icon":0},{"id":"2620112974","title":"机构称伊朗冲突可能导致印度股市进一步下跌10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620112974","media":"环球市场播报","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620112974?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:22","pubTimestamp":1773714120,"startTime":"0","endTime":"0","summary":"据 Emkay Global 称,如果油价在三到四个月内保持在每桶 100 美元,印度 NSE Nifty 50 指数“可能会暴跌至约 21,000 点”,因为这将通过破坏需求和挤压利润率来影响企业盈利。 不过,策略师们表示,此次回调只是暂时的,一旦原油价格恢复到每桶70美元的正常水平,印度的经济和盈利就会复苏,从而提供入场良机。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-17/doc-inhrhavu5498824.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK4588","NFTY","EPI","IND","FLIN","INDA","BK4523","BK4585","PIN","INDY","SCIN","SMIN","INDL"],"gpt_icon":0},{"id":"2619487098","title":"港股异动 | 长风药业(02652)涨超17% 肺动脉高压新药IND获受理 填补国内治疗PH-ILD领域空白","url":"https://stock-news.laohu8.com/highlight/detail?id=2619487098","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619487098?lang=zh_cn&edition=full","pubTime":"2026-03-16 10:02","pubTimestamp":1773626554,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,长风药业涨超17%,截至发稿,涨16.43%,报26.78港元,成交额1220.58万港元。消息面上,3月13日,长风药业宣布,公司自主研发的治疗肺动脉高压及间质性肺疾病相关肺动脉高压的吸入粉雾剂ICF001,其新药临床试验申请已获中国国家药品监督管理局正式受理。ICF001的快速推进,有望使其成为国内首个获批用于治疗PH-ILD的吸入药物,填补这一市场空白,同时为全球数十万计的患者带来生命的曙光。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"ab62decfe9624416502f0a5b97418c66","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0320765489.SGD","02652","IND","BK4588","LU1988902786.USD","BK4585","LU0070302665.USD","LU2264538146.SGD","BK4580","LU1989772840.SGD","BK4161","VXUS","LU1064131342.USD","LU0256863811.USD","BK1191","LU0256863902.USD","LU0208291251.USD","LU0211331839.USD","PH","LU1989772923.USD","LU0417517546.SGD"],"gpt_icon":0},{"id":"2619882190","title":"长风药业(02652)自主研发的吸入粉雾剂候选药物ICF001的IND申请获NMPA受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2619882190","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619882190?lang=zh_cn&edition=full","pubTime":"2026-03-13 21:02","pubTimestamp":1773406944,"startTime":"0","endTime":"0","summary":"智通财经APP讯,长风药业 公布,公司自主研发的吸入粉雾剂候选药物ICF001的新药临床试验申请已获中华人民共和国国家药品监督管理局受理。据悉,ICF001是一款基于前药技术平台自主研发的创新型长效吸入粉雾剂候选药物,专为治疗肺动脉高压及相关严重肺部疾病而设计。ICF001的首发适应症为动脉性肺动脉高压与间质性肺疾病相关肺动脉高压。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413866.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","IND","02652"],"gpt_icon":0},{"id":"2619165172","title":"刘纪鹏:印度股市近年为什么这么牛?与其严格的退市制度密切相关","url":"https://stock-news.laohu8.com/highlight/detail?id=2619165172","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619165172?lang=zh_cn&edition=full","pubTime":"2026-03-13 14:23","pubTimestamp":1773382980,"startTime":"0","endTime":"0","summary":" 3月13日,新浪财经3·15投资者保护论坛举行,中国政法大学商学院教授、资本市场知名专家刘纪鹏主旨演讲。刘纪鹏表示,必须加大退市力度,但前提是建立健全的赔付制度,让“作恶者”承担应有责任,切实保护散户投资者利益。 刘纪鹏指出,当前退市制度面临的核心问题在于赔付机制尚未完善。 他以印度股市为例,指出印度股市近年来表现优异,与其严格的退市制度密切相关。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/marketresearch/2026-03-13/doc-inhqvnzk4106329.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EPI","IND","INDY","SMIN","INDA","NFTY","BK4585","SCIN","BK4523","BK4588","PIN","FLIN","INDL"],"gpt_icon":0},{"id":"2619047168","title":"全球改良机制!长风药业(02652)肺动脉高压新药IND获受理 精准递送平台创新转化再获里程碑","url":"https://stock-news.laohu8.com/highlight/detail?id=2619047168","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619047168?lang=zh_cn&edition=full","pubTime":"2026-03-13 13:35","pubTimestamp":1773380142,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,3月13日,长风药业宣布,公司自主研发的治疗肺动脉高压及间质性肺疾病相关肺动脉高压的吸入粉雾剂ICF001,其新药临床试验申请已获中国国家药品监督管理局正式受理。ICF001 是一款基于前药机制实现长效作用的创新型吸入粉雾剂。该类药物在相关罕见及严重肺部疾病中已确立明确的临床价值及验证的重磅药物潜力。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413494.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IND","BK1191","02652"],"gpt_icon":1},{"id":"2619830157","title":"康宁杰瑞制药-B(09966):JSKN021的IND申请获CDE正式受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2619830157","media":"智通财经网","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619830157?lang=zh_cn&edition=full","pubTime":"2026-03-13 08:04","pubTimestamp":1773360243,"startTime":"0","endTime":"0","summary":"康宁杰瑞制药-B(09966)发布公告,公司自主研发的靶向表皮生长因子受体(EGFR)╱人表皮生长因子受体3(HER3)的双抗双载荷偶联药物(ADC(s))JSKN021新药临床试验(IND)申请,已获国家药监局药品审评中心(CDE)正式受理。","market":"sh","thumbnail":"https://img.zhitongcaijing.com/gonggao/ztcj_announce_33.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/gonggao/ztcj_announce_33.jpeg?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413379.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK1574","BK4017","LU1223083913.SGD","CDE","LU1223082519.USD","BK1161","09966","IND","LU1223082196.USD"],"gpt_icon":0},{"id":"2618189126","title":"海思科(002653.SZ)获得创新药HSK44459乳膏两项适应症IND申请受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2618189126","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618189126?lang=zh_cn&edition=full","pubTime":"2026-03-12 16:01","pubTimestamp":1773302467,"startTime":"0","endTime":"0","summary":"智通财经APP讯,海思科(002653.SZ)发布公告,公司于近日收到国家药品监督管理局下发的《受理通知书》,涉及药品:“HSK44459乳膏”。HSK44459乳膏是公司自主研发的一个全新的具有独立知识产权的治疗银屑病和特应性皮炎的药物。临床前研究结果表明,本品靶点明确、疗效确切、安全性好,是一款极具开发潜力的小分子药物,临床应用的效益/风险比高,具有广阔的临床应用前景,有望成为银屑病和特应性皮炎的有效治疗药物,解决目前临床用药匮乏的难题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1413066.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159992","002653","IND","BK0028","06978","BK0077","BK1161","BK0188","BK0033","BK0239","BK1574"],"gpt_icon":0},{"id":"2618040969","title":"国际油价突破100美元 印度股市跌至11个月低点","url":"https://stock-news.laohu8.com/highlight/detail?id=2618040969","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618040969?lang=zh_cn&edition=full","pubTime":"2026-03-12 12:57","pubTimestamp":1773291436,"startTime":"0","endTime":"0","summary":"印度基准股指连续第二日下跌,民用燃气供应紧张加剧、国际油价飙升,拖累经济增长前景。印度NSE Nifty50指数下跌0.8%,报23,673.05点;标普BSE Sensex指数跌幅相近。本地股市走弱与亚太区域市场抛售一致,全球能源价格波动压制市场情绪。私营银行及汽车股同样走低。中小盘股抛售更为剧烈,相关指数跌幅高达1.9%。印度工业信贷投资银行下跌2%,为Nifty50指数最大拖累个股。Nifty50指数的50只成分股中,4只上涨、46只下跌。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-12/doc-inhqtcuq1840461.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina_us","symbols":["INDL","INDA","INDY","BK4588","PIN","SCIN","NFTY","FLIN","DUG","IND","SMIN","BK4585","BK4523","EPI"],"gpt_icon":0},{"id":"2618055516","title":"英硅智能与Liquid AI达成合作;氢溴酸他泽司他片被召回","url":"https://stock-news.laohu8.com/highlight/detail?id=2618055516","media":"21世纪经济报道","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618055516?lang=zh_cn&edition=full","pubTime":"2026-03-10 08:03","pubTimestamp":1773101006,"startTime":"0","endTime":"0","summary":"政策动向氢溴酸他泽司他片启动召回程序国家医保局3月9日消息显示,和黄医药(中国)有限公司发布公告,对其授权引进产品氢溴酸他泽司他片(商品名:达唯珂)启动撤市及产品召回程序。据此,自2026年3月9日起,撤销氢溴酸他泽司他片在全国各省级医药采购平台挂网,并根据企业申请,将氢溴酸他泽司他片移出《商业健康保险创新药品目录(2025年)》。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603103666774021.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603103666774021.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1820825898.SGD","BK0188","LU2148510915.USD","LU1064130708.USD","BK0028","LU2495084118.USD","LU1064131003.USD","LU1934453819.USD","LU1255011170.USD","LU2488822045.USD","BK0183","BK0060","688621","LU1969619763.USD","LU1655091616.SGD","BK0187","LU1997244956.HKD","LU2289578879.USD","LU2097828631.EUR","BK0175","LU1997245177.USD","LU2097828805.USD","IND","LU1781817850.SGD","LU1979443071.USD","LU1328615791.USD","LU2580892789.USD","BK0196","LU1146622755.USD","LU2097828474.EUR","LU2097828714.EUR","TSLP","LU2097828557.USD","600196","600276","LU1997245094.SGD","BK4160","LU2580892862.HKD","BK0239","002422","LU1580142542.USD","BK0096","LU0405327148.USD","LU0405327494.USD","LU2328871848.SGD","BK0012","GIPR","BK0216"],"gpt_icon":0},{"id":"2618061950","title":"印度卢比下跌0.5%,至1美元兑92.23卢比,因原油价格飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2618061950","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618061950?lang=zh_cn&edition=full","pubTime":"2026-03-09 11:33","pubTimestamp":1773027180,"startTime":"0","endTime":"0","summary":"每经AI快讯,3月9日,印度卢比下跌0.5%,至1美元兑92.23卢比,因原油价格飙升。\n\n\n海量资讯、精准解读,尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-03-09/doc-inhqkhis7023584.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-03-09/doc-inhqkhis7023584.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["INDA","PIN","NFTY","IUmain","BK4523","SCIN","INDL","IND","INDY","BK4588","SMIN","BK4585","EPI","FLIN"],"gpt_icon":0},{"id":"2617550729","title":"港股异动 | 乐普生物-B(02157)午后涨超6% MRG006A 联合疗法IND获批 有望推动肝癌精准治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2617550729","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617550729?lang=zh_cn&edition=full","pubTime":"2026-03-06 15:05","pubTimestamp":1772780726,"startTime":"0","endTime":"0","summary":"乐普生物-B(02157)午后涨超6%,截至发稿,涨5.76%,报4.41港元,成交额3357.41万港元。","market":"us","thumbnail":"https://img.zhitongcaijing.com/image/20260306/20260306150556_78408.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260306/20260306150556_78408.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410906.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4588","VT","VXUS","BK1161","BK4585","02157","IND"],"gpt_icon":0},{"id":"2617509266","title":"港股异动 | 宜明昂科-B(01541)拉升逾16% 阿沐瑞芙普α皮下制剂IMM0306S治疗系统性红斑狼疮IND获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2617509266","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617509266?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:47","pubTimestamp":1772768845,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,宜明昂科-B拉升逾16%,截至发稿,涨15.87%,报4.38港元,成交额947.17万港元。消息面上,3月4日,据宜明昂科官微消息,公司宣布,自主研发的阿沐瑞芙普α皮下注射制剂,用于治疗系统性红斑狼疮的临床试验申请已获得中国国家药品监督管理局的正式批准。此次阿沐瑞芙普α皮下注射制剂治疗系统性红斑狼疮的IND获批,是宜明昂科在自身免疫性疾病领域密集布局的最新成果,也是其“自免管线全面开花”战略的重要体现。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["VT","BK4585","IND","BK4588","BK1161","01541","VXUS"],"gpt_icon":0},{"id":"2617506042","title":"能源命门被卡!印度市场成中东地缘博弈下首个“牺牲品” 大摩下调评级至“持有”","url":"https://stock-news.laohu8.com/highlight/detail?id=2617506042","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617506042?lang=zh_cn&edition=full","pubTime":"2026-03-06 11:10","pubTimestamp":1772766605,"startTime":"0","endTime":"0","summary":"策略师们在最新的调整中将印度的评级从“增持”下调至“持有”,并指出该国是受卡塔尔液化天然气供应潜在中断影响最大的亚洲市场之一。霍尔木兹海峡的长期中断可能会推高石油和液化天然气价格,给依赖能源进口的亚洲带来压力,并引发盈利预测下调。全球投资者正从新兴亚洲的主要市场撤资。自战争开始以来,外国人已从印度撤出了约 13 亿美元,印度的 AI 相关风险敞口较为有限。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IND","INDA","159945","INDL","INDY","SMIN","PIN","NFTY","FLIN","SCIN","EPI"],"gpt_icon":0},{"id":"2617150523","title":"港股异动 | 复宏汉霖(02696)涨超5% 自研KAT6A/B小分子抑制剂HLX97获国家药监局IND许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2617150523","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617150523?lang=zh_cn&edition=full","pubTime":"2026-03-06 10:10","pubTimestamp":1772763011,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,复宏汉霖(02696)涨超5%,截至发稿,涨5.02%,报68港元,成交额1948.15万港元。消息面上,3月5日,复宏汉霖发布公告,近日,本公司自主研发的HLX97(KAT6A/B小分子抑制剂)(HLX97)在晚期/转移性实体瘤患者中的1期临床试验申请(IND)获国家药品监督管理局(NMPA)批准。HLX97是本公司自主研发的赖氨酸乙酰转移酶6A/B(KAT6A/B)小分子抑制剂,拟用于治疗晚期/转移性实体瘤。非临床研究显示, HLX97可抑制KAT6A/B的活性,具有良好的抗肿瘤效果和安全性特征。截至本公告日,于全球范围内尚无KAT6A/B小分子抑制剂获批上市。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1410802.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","HK0000320264.USD","HK0000320223.HKD","IND","VT","HK0000306685.HKD","HK0000306701.USD","VXUS","02696","HK0000165453.HKD","BK4585","BK4588"],"gpt_icon":0},{"id":"2616002683","title":"油价飙升推动印度卢比跌至历史新低","url":"https://stock-news.laohu8.com/highlight/detail?id=2616002683","media":"格隆汇","labels":["economic"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616002683?lang=zh_cn&edition=full","pubTime":"2026-03-04 11:54","pubTimestamp":1772596478,"startTime":"0","endTime":"0","summary":"3月4日,印度卢比跌至历史新低,债券价格下跌。周三卢比兑美元一度下跌0.7%,为1月底以来最大跌幅,至92.0875;与此同时,印度10年期基准国债收益率上升5个基点至6.72%。澳新银行外汇策略师Dhiraj Nim表示:“油价上涨对卢比构成直接风险,我们预计印度央行的干预力度会略有加大,但如果油价维持高位,我们可能不得不接受卢比走弱。”油价上涨重新引发市场对印度通胀的关注,因为该国几乎全部能源需求依赖进口。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://usstock.jrj.com.cn/2026/03/04115456176123.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"economic","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_highlight","symbols":["BK4585","BK4588","IUmain","IND","INDL","INDY","DUG","NFTY","PIN","SCIN","BK4523","EPI","INDA","FLIN","SMIN"],"gpt_icon":0},{"id":"2616384450","title":"中东冲突导致印度股市回吐美欧贸易协议带来的全部涨幅","url":"https://stock-news.laohu8.com/highlight/detail?id=2616384450","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616384450?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:54","pubTimestamp":1772441640,"startTime":"0","endTime":"0","summary":"受中东冲突升级打压投资者情绪,印度股市周一下跌,与亚洲多数市场走势一致。 印度国家证券交易所Nifty 50指数午后下跌1.9%,盘中一度大跌2.1%,为一个多月以来最大跌幅。该基准指数正迈向9月以来的最低水平,回吐了今年2月印美达成贸易协议后录得的全部涨幅。 印度股市中,工程类企业是主要下跌板块之一。 龙头企业Larsen & Toubro超过三分之一的订单来自中东,股价一度暴跌7.4%,创下4月7日以来最大盘中跌幅。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2026-03-02/doc-inhpqvai4604203.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["INDY","BK4585","IND","INDA","PIN","SCIN","BK4523","SMIN","BK4588","NFTY","INDL","FLIN","EPI"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.ing.com","stockEarnings":[{"period":"1week","weight":-0.0335},{"period":"1month","weight":-0.1351},{"period":"3month","weight":-0.149},{"period":"6month","weight":-0.1526},{"period":"ytd","weight":-0.1449}],"compareEarnings":[{"period":"1week","weight":-0.0207},{"period":"1month","weight":-0.055},{"period":"3month","weight":-0.047},{"period":"6month","weight":-0.0228},{"period":"1year","weight":0.1469},{"period":"ytd","weight":-0.0489}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"荷兰国际集团是在1991年由荷兰国民人寿保险公司和荷兰邮政银行集团合并组成的综合性财政金融集团。据美国财富(FORTUNES)杂志统计,以资产净值计算,荷兰国际集团位居全球500家大企业的第64位。在提供综合性金融财经业务方面(银行与保险业务),居世界第三位。目前,该集团在世界上65个国家和地区设有分支机构,雇员超过10万人。2000年,该集团取得税后净利润49亿欧元,同比增长24%。截至2000年底,集团资产总额达5030亿欧元。 管理结构: 在董事会下面设有四个管理运作核心,荷兰总部;国际金融财经业务部;企业和资本市场部;资产管理部。 集团总部:负责荷兰本国市场上的全部保险和银行业务。 国际金融财经业务部:所有荷兰本土以外的国际保险业、零售银行业和商业银行业的运作皆由该中心管理。其保险业务划分三大地区:欧洲和拉丁美洲、北美洲、亚澳地区。银行业务则由中心统一管理。 企业及资本市场部:所有国际货币和资本市场管理部门都由该部门管理。包括国际银行网络以及金融产品、贸易、销售、投资银行、企业银行、风险管理及调研的各项业务。 资产管理部:该部门承担企业投资者的资产和帐目管理、提供个人国际银行服务以及集团公司的保险业务的资产管理。房地产业务和信托业务也属于这个部门管理。该部门同时管理荷兰国际集团各个公司的投资基金。","yearOnYearQuotes":[{"month":1,"riseRate":0.857143,"avgChangeRate":0.027152},{"month":2,"riseRate":0.285714,"avgChangeRate":-0.031592},{"month":3,"riseRate":0.785714,"avgChangeRate":0.035422},{"month":4,"riseRate":0.571429,"avgChangeRate":0.017359},{"month":5,"riseRate":0.285714,"avgChangeRate":0.00595},{"month":6,"riseRate":0.714286,"avgChangeRate":0.006634},{"month":7,"riseRate":0.785714,"avgChangeRate":0.023298},{"month":8,"riseRate":0.4,"avgChangeRate":-0.016348},{"month":9,"riseRate":0.571429,"avgChangeRate":-0.024108},{"month":10,"riseRate":0.785714,"avgChangeRate":0.022259},{"month":11,"riseRate":0.357143,"avgChangeRate":-0.033495},{"month":12,"riseRate":0.642857,"avgChangeRate":0.020836}],"exchange":"NASDAQ","name":"Xtrackers Nifty 500 India ETF","nameEN":"Xtrackers Nifty 500 India ETF"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.37.0","shortVersion":"4.37.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Xtrackers Nifty 500 India ETF(IND)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Xtrackers Nifty 500 India ETF(IND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Xtrackers Nifty 500 India ETF,IND,Xtrackers Nifty 500 India ETF股票,Xtrackers Nifty 500 India ETF股票老虎,Xtrackers Nifty 500 India ETF股票老虎国际,Xtrackers Nifty 500 India ETF行情,Xtrackers Nifty 500 India ETF股票行情,Xtrackers Nifty 500 India ETF股价,Xtrackers Nifty 500 India ETF股市,Xtrackers Nifty 500 India ETF股票价格,Xtrackers Nifty 500 India ETF股票交易,Xtrackers Nifty 500 India ETF股票购买,Xtrackers Nifty 500 India ETF股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Xtrackers Nifty 500 India ETF(IND)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Xtrackers Nifty 500 India ETF(IND)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}